Companies: 10,795·Total market cap: $144.5T
Veracyte, Inc.

Veracyte, Inc.

VCYTNASDAQHealthcare● Active
$47.62
$-1.11(-2.29%)
Market Cap$3.8B
P/E Ratio
52W High$50.71
52W Low$22.61
Overview

Veracyte, Inc.(VCYT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · VCYT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.52B$0.45B$0.36B$0.30B$0.22B
Cost of Revenue$0.16B$0.15B$0.11B$0.10B$0.07B
Gross Profit$0.36B$0.30B$0.25B$0.19B$0.15B
Gross Margin %(computed)69.62%66.88%68.73%65.74%66.11%
Operating Expenses
R&D Expenses$0.07B$0.07B$0.06B$0.04B$0.03B
G&A Expenses$0.11B$0.18B$0.16B$0.08B$0.10B
Total Operating Expenses$0.29B$0.28B$0.33B$0.24B$0.23B
Operating Income$0.07B$0.02B($0.09B)($0.04B)($0.08B)
Operating Margin %(computed)14.34%3.62%-23.76%-13.85%-37.31%
Interest Income$0.00B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.07B$0.03B($0.08B)($0.04B)($0.08B)
Income Tax Expense$0.00B$0.00B($0.00B)$0.00B($0.01B)
Net Income$0.07B$0.02B($0.07B)($0.04B)($0.08B)
Net Margin %(computed)12.83%5.41%-20.61%-12.33%-34.42%
Per Share & EBITDA
EPS (Basic)$0.84$0.32$-1.02$-0.51$-1.11
Wtd Avg Shares0.08B0.08B0.07B0.07B0.07B
EBITDA$0.09B$0.05B($0.05B)($0.01B)($0.06B)
EBITDA Margin %(computed)17.33%11.04%-13.68%-2.35%-27.42%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Veracyte, Inc.

关于Veracyte, Inc.(VCYT)损益表

Veracyte, Inc.(VCYT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,VCYT实现营收$0.52B,毛利润$0.36B(毛利率69.62%),净利润$0.07B(净利率12.83%)。

常见问题

VCYT · 4 问

Veracyte, Inc.(VCYT)2025财年营收为$0.52B,同比up16.0%。

VCYT revenueVCYT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08